Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Antineoplastic agents>Other antineoplastic Drugs>Cediranib
Cediranib
  • Cediranib

Cediranib

Price $1
Package 1g
Min. Order: 1g
Supply Ability: 500ton
Update Time: 2024-01-08

Product Details

Product Name: Cediranib CAS No.: 288383-20-0
Min. Order: 1g Purity: 99%
Supply Ability: 500ton Release date: 2024/01/08
Density1.3±0.1 g/cm3
Boiling point626.6±55.0 °C at 760 mmHg
Molecular formulaC25H27FNfourOthree
Molecular weight450.505
Flash point332.7±31.5 °C
Accurate mass450.206726
PSA72.50000
LogP4.80
vapour pressure0.0±1.8 mmHg at 25°C
Refractive index1.642
describeCediran IB Malte (AZD-2171 Malte) is a highly selective VEGFR2 inhibitor with oral activity. Its IC50 values for Flt1, KDR, Flt4, PDGFRα, PDGFRβ and c-Kit are less than 1, less than 3, 5, 5, 36 and 2nM, respectively.
Related categories
Signal path%3E%3Eautophagy%3E%3Eautophagy
Signal path%3E%3EProtein tyrosine kinase%3E%3EPDGFR
Research field%3E%3ECancer
target spot

Flt-1:5 nM (IC50)

KDR:1 nM (IC50)

Flt-4:3 nM (IC50)

PDGFRα:36 nM (IC50)

PDGFRβ:5 nM (IC50)

c-Kit:2 nM (IC50)

In vitro studyIn human umbilical vein endothelial cells, cetinib inhibited VEGF-stimulated proliferation and KDR phosphorylation with IC50 values of 0.4 and 0.5 nM, respectively. In the co-culture model of fibroblasts/endothelial cells with sprouting blood vessels, cetinib also reduced the area, length and branches under sub-nanomolar concentration of blood vessels [1].
In vivo studyCediranib can eliminate experimental (VEGF-induced) angiogenesis and inhibit intraosseous ossification in ovary or cartilage in corpus luteum development. Physiological processes are highly dependent on neovascularization. The growth of human tumor xenografts (colon, lung, prostate, breast and ovary) established in athymic mice was inhibited by cetinib in a dose-dependent manner. Long-term administration of 1.5mg/kg/day produced statistically significant inhibition in all models. Histological analysis of Calu-6 lung tumor treated with Cediranib showed that the microvessel density decreased within 52 hours and gradually increased with the duration of treatment. These changes indicate the degeneration of blood vessels in tumors.
Kinase experimentA series of recombinant tyrosine kinases [KDR, Flt-1, Flt-4, c-Kit, PDGFR-α, PDGFR-β, CSF-1R, Flt-3, FGFR1, Src, Abl] were used to determine the inhibitory activity of cetinib. Epidermal growth factor receptor (EGFR), ErbB2, Aur-A and aur-b were detected by ELISA.
Cell experimentPDGF-AA induces the proliferation of MG63 osteosarcoma cells, which selectively activates PDGFR-α homodimer signal transduction. Cells were cultured in DMEM without phenol red containing 1% FCS stripped from activated carbon, 2mM glutamine and 1% non-essential amino acids for 24 hours. PDGF-AA ligand (50ng/mL) was added to cetinib or carrier, and the plate was re-cultured for 72 hours. Cell proliferation was determined by bromodeoxyuridine [1].
Animal experimentRats: Young female Alderley Park rats (6 weeks old, Wistar-derived, n = 5) were given orally once a day, and were treated with cidinib (1.25-5mg/kg/day) or vehicle for 28 days. Additional rats (5 rats in each group) were treated with cetinib (5mg/kg/day) or vehicle for 28 days, and maintained for another 28 days without treatment to check the effect of compound withdrawal. Histological paraffin sections of femoral and tibial joints and ovaries were stained with H&E. The morphological image analysis of femur and tibia section was carried out, and the growth plate regions from femur and tibia in each joint were combined to analyze the effect of compound treatment. The area of corpus luteum in H&E stained ovarian sections was similarly determined by morphometric analysis [1]. Mice: The mice (day 0) carrying the established Calu-6 human lung tumor xenograft (0.2±0.01cm 3) were selected and treated with cetinib (6mg/kg/day, po) or carrier for a long time. On days 1, 2, 7, 14 and 21, tumors (6-15 in each group) were collected 4 hours after the last dose of cetinib or vector. Then cd31 was detected in the section using chromophore endpoint or fluorescence immunostaining [1]].

Inquiry guide

1. Please send the quantity(Weight) to us, we will arrange our sales to provide the one-for-one service for you.

2.Then we will provide the professional quotation list for you, it will be including all the factors in whole business process(Quality, shipping, payment, files etc.).

3.If you have many products need inquiry, please send the list for us, the product clear information includes CAS + Name + quantity(Weight), we will provide the complete solution for you. We also provide the customization product.

We are the Qualified suppliers of 24 famous listed international companies, including Pharmaceutical R&D agencies, New material factories, Wholesale trader of chemical reagent etc.  

 

Profile

 

Hebei Zhuangkai Biotechnology Co. Ltd , mainly produces pharmaceutical raw

 

materials, pharmaceutical intermediates and refined products.Seek 

 

development by credit reputation.Our products have a low price 

 

advantage in Europe, South America and so on.

    

 Superiorit

 

 1.we have over 10 years experiencein this aera

 

2.As first cooperation,when we got your payment,would arrange cargo for 

 

you.If the cargo delay,we would return payment.If the cargo lose,we'll reschedule it

 

for you

 3.The most important thing,Regular customer,sample could be supply for you by free!

 

4.we are attention to every customer's requirements and make a good relationship with them.

 

  Our company also has the advantage of high quality in Africa.In the 

 

past two years, our products has reached more than 30 countries in the 

 

world, and Europe.South America.North America, southeast Asia, Africa, 

 

etc.

 

 We welcome friends all over the world the best quality and best price 

 

mutual cooperation and common development!  

 

 


Company Profile Introduction

-WUHAN BOYUAN IMPORT & EXPORT CO.,LTD.. is specialized in R&D, manufacturing and marketing APIS, Food Additives,Inorganic Chemicals,Organic Intermediate,Health Care Products,Feed Additives,Chemical Reagents,Daily Chemicals etc.More than 70 percent products are exported to Europe, America, Japan and Southeast Asia. In the past years, WUHAN BOYUAN IMPORT & EXPORT CO.,LTD. has established its professional team and advanced managements, excels in product sourcing and customized products. WUHAN BOYUAN IMPORT & EXPORT CO.,LTD. has built close collaborations with several well-known institutes in China. Development of new fine chemical, custom synthesis has been a significant part of our chemical's production. The essence of our business is commitment to customer service by meeting and/or exceeding our client's expectations of cost, quality, and efficient service. We are confident that our competitive edge will provide the foundation ensure for our customers to be successful in their own market areas. Our company offers variety of products which can meet your multifarious demands. We adhere to the management principles of "quality first, customer first and credit-based" since the establishment of the company and always do our best to satisfy potential needs of our customers. Our company is sincerely willing to cooperate with enterprises from all over the world in order to realize a win-win situation since the trend of economic globalization has developed with anirresistible force

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/25KG
VIP4Y
Hebei Mojin Biotechnology Co., Ltd
2023-09-06
$12.00/1KG
Hong Kong Tiansheng New Material Trading Co., Ltd
2022-01-10
$1.10/1g
VIP3Y
Dideu Industries Group Limited
2021-07-01
$10.00/1PCS
VIP6Y
Hebei Guanlang Biotechnology Co., Ltd.
2021-03-12
$0.00/1Kg
VIP5Y
Shaanxi Dideu Medichem Co. Ltd
2020-04-30
$2.00/1kg
VIP6Y
Career Henan Chemical Co
2018-12-24
$5.99/1KG
Hong Kong Tiansheng New Material Trading Co., Ltd
2021-12-24
  • Since: 2014-04-18
  • Address: Hong Kong
INQUIRY
mike
+86-15175982296
Mike@whby-chem.com